MiniMed (MNMD) shares gained for the first time in five sessions on Tuesday as Medtronic’s (MDT) diabetes business received multiple bullish views on Wall Street as its post-IPO quiet period ended.

Years after being absorbed by Medtronic, Northridge-based MiniMed Group has spun off on its own again and went through an IPO. Chief Executive Que Dallara at the ribbon cutting ceremony for MiniMed in ...

MiniMed, a global leader in diabetes technology, announced US Food and Drug Administration (FDA) clearance of MiniMed Flex, a next-generation discreet, smartphone-controlled insulin pump designed to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Minimed Group Inc. secured U.S. FDA approval for Minimed Flex, its next-generation discreet, smartphone-controlled insulin pump. The nod from the FDA follows the company’s debut on Nasdaq March 6.

MiniMed Flex™ is about half the size of the previous generation MiniMed™ 780G system, and features the SmartGuard™ adaptive algorithm to automatically adjust and autocorrect insulin delivery in ...

MiniMed Flex™ is about half the size of the previous generation MiniMed™ 780G system, and features the SmartGuard™ adaptive algorithm to automatically adjust and autocorrect insulin delivery in ...

MiniMed Group (MMED) lost ~5% as Medtronic’s (MDT) diabetes business began trading as a public company on Thursday following its separation from the parent via an IPO that raised $560M for the insulin ...

March 6 (Reuters) - Medtronic's (MDT.N), opens new tab diabetes business MiniMed (MMED.O), opens new tab shares opened 4.8% below their offer price in Nasdaq debut on Friday, valuing it at $5.35 ...

GALWAY, Ireland and NORTHRIDGE, Calif., March 5, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed), a subsidiary of Medtronic plc (Medtronic) (NYSE: MDT), today announced the pricing of its initial ...

Pricing shares at $20 each, below the intended price range, insulin delivery company Minimed Group Inc. debuted with an IPO on Nasdaq March 6, raising $560 million. The company offered a total of 28 ...